Expression of bovine interleukin 15 and evaluation of its biological activity in vitro

N Vijay1, J Lijo1, H J Dechamma1

  • 1FMD Research Laboratory, Indian Veterinary Research Institute, Hebbal, Bangalore, Karnataka, India.

Veterinary World
|April 6, 2016
PubMed

Insights

Bovine interleukin-15 (IL-15) was cloned and expressed, showing biological activity. This cytokine enhances memory T cell survival, suggesting its use as a vaccine adjuvant to boost immunity.

Area of Science:

  • Veterinary Immunology
  • Molecular Biology
  • Vaccinology

Background:

  • Interleukin-15 (IL-15) is crucial for CD8(+) T cell development and memory formation.
  • Understanding bovine IL-15 (bIL-15) function is key for improving vaccine efficacy in cattle.

Purpose of the Study:

  • To clone and express functional bovine IL-15 (bIL-15).
  • To investigate the role of bIL-15 in activating bovine CD8(+) T cells.
  • To evaluate bIL-15 as a potential adjuvant for enhancing vaccine-induced immunity.

Main Methods:

  • Amplification and cloning of bIL-15 coding and mature sequences.
  • Expression and purification of bIL-15 fusion protein.
  • Analysis of protein expression via SDS-PAGE and Western blotting.
  • Assessment of biological activity using qPCR to measure Bcl2, STAT3, STAT5a, and CPT1a levels in stimulated PBMCs.

Main Results:

  • Successfully amplified and cloned bIL-15 sequences.
  • Purified bIL-15 fusion protein (32kDa) demonstrated biological activity.
  • bIL-15 significantly upregulated Bcl2 (5-fold), STAT3 (9-fold), and STAT5a (10-fold) mRNA levels.
  • bIL-15 increased Carnitine Palmitoyl Transferase 1a (CPT1a) expression by 2.5-fold, indicating enhanced memory T cell survival.

Conclusions:

  • Bovine IL-15 was successfully cloned, expressed, and confirmed to be biologically active.
  • The observed increase in CPT1a suggests bIL-15 promotes memory T cell survival.
  • bIL-15 holds potential as an adjuvant in viral vaccines to prolong immunity in cattle.
Abstract

Related Concept Videos